R&D Archives

APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer

APIE Therapeutics appoints Robert Willette, Ph.D. to the newly created role of chief scientific officer.

Contact us to get more information about the company and the compelling nonclinical studies results that supports moving the program into human clinical trials.

QUICK CONTACT

USEFUL LINKS